Intra-Cellular Therapies, Inc. (ITCI)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 72.13 |
| 開市 | 72.27 |
| 買盤 | 73.22 x 200 |
| 賣出價 | 73.36 x 400 |
| 今日波幅 | 71.66 - 73.52 |
| 52 週波幅 | 45.50 - 84.89 |
| 成交量 | |
| 平均成交量 | 963,533 |
| 市值 | 7.718B |
| Beta 值 (5 年，每月) | 1.01 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.46 |
| 業績公佈日 | 2024年5月02日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 91.91 |
ZacksWill Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know
Intra-Cellular (ITCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insider Monkey10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
Investor's Business DailyBiotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point
Intra-Cellular stock: Shares rocketed more than 23% Tuesday, sending them past their latest buy point on the stock market today.
